<DOC>
	<DOCNO>NCT00561886</DOCNO>
	<brief_summary>Chronic obstructive bronchitis emphysema ( COPD ) pathophysiologically characterize inflammatory structural change lung . These change lead reduction elastic recoil well reduction lung parenchyma . As consequence collapse small airway occur expiration lead expiratory flow limitation . In severe case flow limitation occur even rest condition . This expiratory collapse suspect mask change bronchial smooth muscle tone , especially change bronchial smooth muscle tone assess use expiratory manoeuvre . This might leave impression non-reversible airway obstruction und ineffectiveness treatment bronchodilator . Several study suggest patient COPD symptomatic change follow application bronchodilating compound correlate change force expiratory volume . In contrast inspiratory lung function parameter ( especially force inspiratory volume one second ( FIV1 ) ) much associate symptomatic change patient COPD . Comparable effect also detect regard peak inspiratory flow ( PIF ) values.Changes inspiratory parameter follow administration bronchodilator patient COPD asthma reproducible . PIF easily measure inspiratory peak flow meter . So far data exists usability device follow bronchodilation patient COPD . Formoterol rapid act bronchodilator , proven save asthma COPD</brief_summary>
	<brief_title>Change Inspiratory Peak Flow COPD</brief_title>
	<detailed_description>N=40 patient moderate severe COPD ( 30 &lt; FEV1 &lt; 70 % pred . ) , significant lung disease ; current smoker ex-smokers ; exacerbation last 2 month . Baseline visit Physical examination Dsypnea score ( Borg-Scale , TDI ) Lung function ( Bodyplethysmography , CO-diffusion capacity ) Before study day follow medication withhold : Short-acting bronchodilator &gt; 6 hour Long-acting b2-adrenoceptor agonist &gt; 24 hour Tiotropium &gt; 24 hour Study day 1 Bodyplethysmography include FEV1 , PEF , FIV1 PIF assessment PIF use inspiratory Peak Flow Meter randomize order . Dysnpea Scores 30 minute break Assessment change dyspnea ( visual analogue scale ) Bodyplethysmography include FEV1 , PEF , FIV1 PIF . Assessment PIF use inspiratory Peak Flow Meter randomize order Administration 12 Âµg formoterol 30 minute break Assessment change dyspnea ( visual analogue scale ) Bodyplethysmography include FEV1 , PEF , FIV1 PIF . Assessment PIF use inspiratory Peak Flow Meter randomize order . Study day 2 Three 14 day follow study day 1 . Schedule like day 1 change order lung function test depend randomization .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>1 . Patients COPD moderate severe degree accord GOLD guideline 2. current exsmokers , history atopy , stable clinical condition , age &gt; 40 year . 1 . Significant lung disease COPD , unstable clinical condition 2. acute exacerbation last 2 month</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>COPD</keyword>
	<keyword>lung function</keyword>
	<keyword>dysnpea</keyword>
</DOC>